The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuantum Pharma Share News (QP.)

  • There is currently no data for QP.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quantum Pharma Profit Surges And Dividend Hiked After Strong Year

Tue, 10th May 2016 07:27

LONDON (Alliance News) - Niche pharmaceuticals company Quantum Pharma PLC on Tuesday said its pretax profit surged in its financial year to the end of January due to lower financing costs as revenue grew.

Quantum said its pretax profit for the year to the end of January was GBP6.2 million, compared to GBP1.1 million a year earlier, mainly due to the group having booked GBP5.6 million in financing costs the year before.

Revenue grew to GBP70.0 million from GBP61.7 million, helped by the acquisitions of Lamda and NuPharm, investments made in its senior management team, the launch of products under its Mucodis range, and the out-licence of its Avitol capsules to a German pharmaceutical company.

The group also delivered significant tender and contract wins in its homecare business and made progress on developing its Biodose Connect product.

Quantum added that its product pipeline has grown significantly, both in terms of size and value.

Quantum will pay a 1.0 pence per share final dividend, taking its total payout to 1.5p. That compares to the 0.25p final dividend only paid out for the previous financial year.

Chief Executive Andrew Scaife said trading so far in 2016 has been strong, giving the group confidence on the outlook for the full current financial year.

"During the past year, we have made progress in developing several key aspects of Quantum Pharma's business, to put in place a strong platform from which the group can deliver its strategy. We have improved the group's infrastructure and management, and reviewed and significantly improved our processes around monitoring and delivery of the product pipeline, in addition to receiving external validation of its potential value," said Scaife.

"I am excited about the potential of the product pipeline and am pleased that, since the year end, we have received marketing authorisations or approvals to launch three new licensed products with five product lines into the UK market," he added.

Shares in Quantum were up 6.2% to 64.50p.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
16 Jul 2015 05:15

AGM, EGM Calendar - Week Ahead

Read more
15 Jul 2015 15:14

AGM, EGM Calendar - Week Ahead

Read more
15 Jul 2015 05:18

AGM, EGM Calendar - Week Ahead

Read more
14 Jul 2015 14:59

AGM, EGM Calendar - Week Ahead

Read more
14 Jul 2015 09:34

Quantum Pharma completes NuPharm acqusition

(ShareCast News) - Pharmaceutical manufacturer and developer Quantum Pharma has completed the acquisition of NuPharm in a deal worth up to £13.3m. The group said it will pay £9.34m in cash upon completion of the deal with up to an additional £4m potentially payable under earn-out agreements. In a s

Read more
14 Jul 2015 08:19

Quantum Pharma Buys NuPharm Group For Up To GBP13.9 Million

Read more
31 May 2015 16:40

Sunday share tips: Lloyds Banking, Quindell, Quantum Pharmaceutical

Lloyds Banking Group shares are a 'hold', said Questor in the Sunday Telegraph. The bank is certainly making progress: reporting rising profits, is close to returning to paying a dividends and small investors will soon able to take advantage of the accelerated sale of the government's shareholding.

Read more
20 May 2015 09:38

Quantum Pharma Hits New Heights As Its Swings To Profit

Read more
17 Apr 2015 10:32

Quantum Pharma completes Lamda takeover

Pharmacy and hospital supplier Quantum Pharma has agreed a €9.7m (£7m) deal to acquire pharmaceutical development company Lamda. Under the agreement, the County-Durham based group will take control of 100% of the share capital of Lamda (UK) Ltd, Lamda Laboratories SA and Lamda Pharmaceuticals SA, wh

Read more
17 Apr 2015 06:28

Quantum Pharma Acquires Lamda Companies For EUR9.7 Million

Read more
9 Feb 2015 07:50

Quantum Pharma To Beat Market View On Progress Across Business

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.